<DOC>
	<DOCNO>NCT02449187</DOCNO>
	<brief_summary>A randomized , open-label , single dose , crossover study investigate effect food pharmacokinetics JLP-1310 healthy male volunteer .</brief_summary>
	<brief_title>Investigate Effect Food Pharmacokinetics JLP-1310 Healthy Male Volunteers</brief_title>
	<detailed_description>A randomized , open-label , single dose , crossover clinical trial .</detailed_description>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>1 . Healthy male volunteer , age 19 year 2 . Body weight 55kg , The result Body Mass Index ( BMI ) less 17.5 kg/m2 , 30.5 kg/m2 3 . Subject ability comprehend study objective , content property study drug participate trial 4 . Subject ability willingness participate whole period trial 1 . Presence medical history concurrent disease may interfere treatment safety assessment completion clinical study , include clinically significant disorder kidney , liver , cardiovascular system , respiratory system , endocrine system , neuropsychiatric system . 2 . Subjects allergic investigational drug . 3 . Subjects medical history affect clinical trial . 4 . Hypertension ( Systolic BP ≥ 140mmHG Diastolic BP ≥ 90mmHg ) , Liver enzyme ( AST , ALT ) level exceeds maximum normal range one half time . 5 . History drug abuse positive drug screening . 6 . Participation drug study within 3 month prior drug administration . 7 . Whole blood donation within 60 day , blood component donation within 30 day get transfusion within 30days .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>